logo
Select company
Select metric
Ticker Information

Ticker

MTNB

Company Name

MATINAS BIOPHARMA HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

MATINAS BIOPHARMA HOLDINGS INC - Cost of Revenue Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MTNB - COGS % Historical data
DateCost of RevenueCost of Revenue MarginRevenues
6/30/2025$ 00%$ 0
3/31/2025$ 00%$ 0
12/31/2024$ 00%$ 0
9/30/2024$ 00%$ 0
6/30/2024$ 00%$ 0
3/31/2024$ 00%$ 0
12/31/2023$ 00%$ 1.1M
9/30/2023$ 00%$ 4.28M
6/30/2023$ 00%$ 4.28M
3/31/2023$ 00%$ 4.28M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MATINAS BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) COGS % stands at 0%.
  • Over the past 5 years, MATINAS BIOPHARMA HOLDINGS INC's average COGS % has been 0%.
  • The median COGS % for MATINAS BIOPHARMA HOLDINGS INC during this period was 0%
  • MATINAS BIOPHARMA HOLDINGS INC reached its highest COGS % over the past 5 years at 0%.
  • The lowest COGS % recorded by MATINAS BIOPHARMA HOLDINGS INC in the same timeframe 0%

Definition of Cost of Revenue Margin

[Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
COGS / Revenues
(=) COGS %
COGS % for MATINAS BIOPHARMA HOLDINGS INC is calculated as follows: COGS [ $ 0 ] / Revenues [ $ 0 ]
(=) COGS % [ 0% ]

MTNB - Cost of Revenue Margin, Last 5 years

0%

Minimum

Dec 31, 2022

0%

Maximum

Dec 31, 2022

0%

Average

0%

Median

COGS % Benchmark Analysis

The chart above depicts the distribution of COGS % for companies in the Total Stock Market. The average COGS % of the companies is 46.87% with a standard deviation of 31.57%.
The following table provides additional summary stats:
COGS % in the Market:
filtered constituents3.8K
min-50.26%
max172.25%
average46.87%
median50.52%
std31.57%